Literature DB >> 21564422

Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice.

A Stengel1, M Goebel-Stengel, L Wang, M Larauche, J Rivier, Y Taché.   

Abstract

BACKGROUND: Corticotropin-releasing factor (CRF) signaling induced by stress is well established to delay gastric emptying (GE) and stimulate colonic functions. The somatostatin receptor (sst(1-5) ) agonist, ODT8-SST acts in the brain to inhibit stress-induced adrenocorticotropic hormone and epinephrine secretion. We investigated whether ODT8-SST acts in the brain to influence stress-related alterations of gastric and colonic motor function and sst receptor subtype(s) involved.
METHODS: Peptides were injected intracerebroventricularly (i.c.v.) under short isoflurane anesthesia and GE, fecal pellet output (FPO) and distal colonic motility monitored in conscious mice. KEY
RESULTS: The stress of acute anesthesia/vehicle i.c.v. injection reduced GE by 67% and increased defecation by 99% compared to non-injected controls. Both responses were abolished by ODT8-SST (1μg= 0.75nmol) or sst(1) agonist (0.65-1.95nmol). The sst(1) agonist (1.95nmol) also prevented the abdominal surgery-induced delayed GE. Octreotide (sst(2)  >sst(5)  > sst(3) ) and the sst(2) or sst(4) agonists (1μg=0.78 or 0.70nmol, respectively) injected i.c.v. did not influence FPO while i.c.v. somatostatin-28 mimicked ODT8-SST's effect. The ODT8-SST-induced increased food intake was inhibited by i.c.v. sst(2) antagonist while the reduced FPO was unchanged. ODT8-SST i.c.v. reduced distal colonic motility in semi-restrained mice compared with vehicle and blocked water avoidance- and i.c.v. CRF (0.5μg=0.09nmol)-induced stimulated FPO while a similar colonic secretomotor response to i.p. 5-hydroxytryptophane (10mgkg(-1) =36.4μmol kg(-1) ) was unaltered. Conclusions & Inferences  ODT8-SST counteracts stress/i.c.v. CRF-related stimulation of colonic motor function and delayed GE which can be reproduced mainly by activation of sst(1) receptors. These data opens new insight to brain somatostatinergic signaling pathways interfering with brain circuitries involved in gut motor responses to acute stress.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21564422      PMCID: PMC3683311          DOI: 10.1111/j.1365-2982.2011.01706.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  66 in total

Review 1.  Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies.

Authors:  S Schulz; M Händel; M Schreff; H Schmidt; V Höllt
Journal:  J Physiol Paris       Date:  2000 May-Aug

2.  Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers.

Authors:  M Rocheville; D C Lange; U Kumar; R Sasi; R C Patel; Y C Patel
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

3.  Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1).

Authors:  J E Rivier; C Hoeger; J Erchegyi; J Gulyas; R DeBoard; A G Craig; S C Koerber; S Wenger; B Waser; J C Schaer; J C Reubi
Journal:  J Med Chem       Date:  2001-06-21       Impact factor: 7.446

4.  Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.

Authors:  Christy Rani R Grace; Judit Erchegyi; Steven C Koerber; Jean Claude Reubi; Jean Rivier; Roland Riek
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

5.  Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.

Authors:  D Feuerbach; D Fehlmann; C Nunn; S Siehler; D Langenegger; R Bouhelal; K Seuwen; D Hoyer
Journal:  Neuropharmacology       Date:  2000-06-08       Impact factor: 5.250

6.  Neuropeptide Y in the paraventricular nucleus of the hypothalamus stimulates colonic transit by peripheral cholinergic and central CRF pathways.

Authors:  H Mönnikes; J Tebbe; C Bauer; C Grote; R Arnold
Journal:  Neurogastroenterol Motil       Date:  2000-08       Impact factor: 3.598

7.  Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery.

Authors:  D Fehlmann; D Langenegger; E Schuepbach; S Siehler; D Feuerbach; D Hoyer
Journal:  J Physiol Paris       Date:  2000 May-Aug

8.  Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats.

Authors:  V Martínez; J Rivier; D Coy; Y Taché
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

9.  Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF.

Authors:  M A Pelleymounter; M Joppa; M Carmouche; M J Cullen; B Brown; B Murphy; D E Grigoriadis; N Ling; A C Foster
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

10.  Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1- and corticotrophin-releasing factor 1 receptor activation.

Authors:  J J Tebbe; S Mronga; C G Tebbe; E Ortmann; R Arnold; M K-H Schäfer
Journal:  J Neuroendocrinol       Date:  2005-09       Impact factor: 3.627

View more
  12 in total

Review 1.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

2.  Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice.

Authors:  Agata Mulak; Muriel Larauche; Mandy Biraud; Mulugeta Million; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2014-11-05       Impact factor: 3.750

Review 3.  Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2012-12-31       Impact factor: 3.750

4.  Impaired propulsive motility in the distal but not proximal colon of BK channel β1-subunit knockout mice.

Authors:  M France; Y Bhattarai; J J Galligan; H Xu
Journal:  Neurogastroenterol Motil       Date:  2012-07-26       Impact factor: 3.598

5.  Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital.

Authors:  Michael Hwang; Rosene Pirrello; Minya Pu; Karen Messer; Eric Roeland
Journal:  Support Care Cancer       Date:  2013-06-04       Impact factor: 3.603

Review 6.  Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 7.  Central somatostatin signaling and regulation of food intake.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

8.  Patterns of Brain Activation and Meal Reduction Induced by Abdominal Surgery in Mice and Modulation by Rikkunshito.

Authors:  Lixin Wang; Sachiko Mogami; Seiichi Yakabi; Hiroshi Karasawa; Chihiro Yamada; Koji Yakabi; Tomohisa Hattori; Yvette Taché
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

Review 9.  Activation of Brain Somatostatin Signaling Suppresses CRF Receptor-Mediated Stress Response.

Authors:  Andreas Stengel; Yvette F Taché
Journal:  Front Neurosci       Date:  2017-04-25       Impact factor: 4.677

10.  Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.